adamantane has been researched along with Angioedema in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greve, J; Hahn, J; Hoffmann, TK; Trainotti, S | 1 |
| Buclin, T; Grouzmann, E; Livio, F | 1 |
| Brown, NJ; Byiers, S; Carr, D; Maldonado, M; Warner, BA | 1 |
| Itoh, H; Saisho, Y | 1 |
4 other study(ies) available for adamantane and Angioedema
| Article | Year |
|---|---|
Drug-Induced Inhibition of Angiotensin Converting Enzyme and Dipeptidyl Peptidase 4 Results in Nearly Therapy Resistant Bradykinin Induced Angioedema: A Case Report.
Topics: Adamantane; Aged, 80 and over; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Ramipril; Tongue Diseases | 2017 |
Angiotensin-converting enzyme and dipeptidyl peptidase IV inhibitors: an increased risk of angioedema.
Topics: Adamantane; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Drug Synergism; Humans; Models, Biological; Nitriles; Pyrrolidines; Risk Factors; Vildagliptin | 2009 |
Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema.
Topics: Adamantane; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Drug Synergism; Humans; Meta-Analysis as Topic; Nitriles; Pyrrolidines; Risk Factors; Vildagliptin | 2009 |
Dipeptidyl peptidase-4 inhibitors and angioedema: a class effect?
Topics: Adamantane; Aged; Angioedema; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Substitution; Humans; Male; Nitriles; Piperidines; Pyrrolidines; Uracil; Vildagliptin | 2013 |